MedPath

Comparative study of Haridradi Parisheka and Moxifloxacin eye drop in anjananamika i. e stye

Phase 1/2
Not yet recruiting
Conditions
Hordeolum (externum) (internum) ofeyelid,
Registration Number
CTRI/2020/02/023619
Lead Sponsor
SanGuruji Arogya Kendra
Brief Summary

This study is randomised comparative clinical trial to study the effect of Haridradi Parisheka and moxifloxacine 0.5% eye drop in Anjannamika. As there is need of easy Ayurvedic treatment to avoid reccurence of stye .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
48
Inclusion Criteria
  • 1.patients having signs and symptoms of Anjannamika 2.patients irrespective of gender and religion.
  • 3.patients of age group 19-50 years.
Exclusion Criteria
  • 1.patients having active systemic disease,auto immune disease acute respiratory distress or other febrile conditions etc 2.
  • Patients having any corneal involvement,uveitis,conjunctivitis,any structural eye deformiity.
  • 3.patient not willing for trial.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A comparative clinical trial to study the efficasy of Haridradi Parisheka and Moxifloxacin 0.5% eye drop in Anjannamika i.e. Stye.3 weeks
Secondary Outcome Measures
NameTimeMethod
Cure of Anjannamika and reduced recurrence18 months

Trial Locations

Locations (1)

Sane Guruji Arogya Kendra, Malwadi Road, Hadapsar, Pune

🇮🇳

Pune, MAHARASHTRA, India

Sane Guruji Arogya Kendra, Malwadi Road, Hadapsar, Pune
🇮🇳Pune, MAHARASHTRA, India
Vd Darshan Chandrakant Dhage
Principal investigator
9511296832
dhagedarshan.18@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.